|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
18.67(B) |
Last
Volume: |
667,954 |
Avg
Vol: |
1,170,540 |
52
Week Range: |
$120.62 - $144.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 724 |
Guru Rank Value : 1.3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,760 |
18,097 |
18,097 |
100,860 |
Total Sell Value |
$246,400 |
$2,309,019 |
$2,309,019 |
$14,306,288 |
Total People Sold |
1 |
4 |
4 |
6 |
Total Sell Transactions |
1 |
7 |
7 |
21 |
End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Guinan Mark |
Executive Vice President & CFO |
|
2020-06-08 |
4 |
AS |
$116.81 |
$8,510,585 |
D/D |
(72,596) |
73,579 |
|
3% |
|
Guinan Mark |
Executive Vice President & CFO |
|
2020-06-08 |
4 |
OE |
$71.17 |
$5,166,657 |
D/D |
72,596 |
146,175 |
|
- |
|
Gregg Vicky B |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
13,844 |
|
- |
|
Main Timothy L |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
19,588 |
|
- |
|
Ring Timothy M |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
20,505 |
|
- |
|
Lassiter Wright Iii |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
1,882 |
|
- |
|
Stanzione Daniel |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
39,572 |
|
- |
|
Wilensky Gail R |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
16,482 |
|
- |
|
Pfeiffer Gary M |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
21,513 |
|
- |
|
Torley Helen |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
4,897 |
|
- |
|
Morrison Denise M |
Director |
|
2020-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,531 |
3,783 |
|
- |
|
Deppe Michael J |
VP, Corp. Controller & CAO |
|
2020-05-18 |
4 |
D |
$107.42 |
$537 |
D/D |
(5) |
25,035 |
|
- |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2020-04-27 |
4 |
AS |
$110.00 |
$555,075 |
D/D |
(5,000) |
22,390 |
|
-6% |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2020-04-27 |
4 |
AS |
$112.01 |
$1,312,433 |
D/D |
(11,717) |
237,747 |
|
-6% |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2020-04-27 |
4 |
OE |
$71.17 |
$833,899 |
D/D |
11,717 |
249,464 |
|
- |
|
Davis J. E. |
EVP, General Diagnostics |
|
2020-03-16 |
4 |
AS |
$85.59 |
$308,251 |
D/D |
(3,513) |
38,086 |
|
45% |
|
Lassiter Wright Iii |
Director |
|
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
351 |
351 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2020-03-11 |
4 |
AS |
$104.25 |
$260,729 |
D/D |
(2,501) |
68,411 |
|
29% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2020-03-11 |
4 |
AS |
$104.25 |
$226,744 |
D/D |
(2,175) |
40,087 |
|
29% |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2020-03-10 |
4 |
D |
$106.46 |
$267,960 |
D/D |
(2,517) |
27,390 |
|
- |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2020-03-10 |
4 |
A |
$106.46 |
$534,216 |
D/D |
5,018 |
29,907 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2020-03-10 |
4 |
D |
$106.46 |
$412,000 |
D/D |
(3,870) |
73,579 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2020-03-10 |
4 |
A |
$106.46 |
$818,997 |
D/D |
7,693 |
77,449 |
|
- |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2020-03-10 |
4 |
AS |
$112.19 |
$11,219 |
D/D |
(100) |
237,747 |
|
19% |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2020-03-10 |
4 |
OE |
$71.17 |
$7,117 |
D/D |
100 |
237,847 |
|
- |
|
787 Records found
|
|
Page 12 of 32 |
|
|